Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma

International Journal of Oncology

Volumn 35, Issue 6, 2009, Pages 1257-1264

  Kim, Jeong Kyu ^a   Jung, Kwang Hwa ^a   Noh, Ji Heon ^a   Eun, Jung Woo ^a   Bae, Hyun Jin ^a   Xie, Hong Jian ^a   Ahn, Young Min ^b   Ryu, Jae Chun ^c   Park, Won Sang ^a   Lee, Jung Young ^a   Nam, Suk Woo ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

Author keywords

Apoptosis; Cell cycle; Cell growth; Hepatocellular carcinoma; S100P

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; PROTEIN S 100; CARRIER PROTEIN; CDK2 PROTEIN, HUMAN; NUCLEAR PROTEIN; S100PBP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER MORTALITY; CANCER PREVENTION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 73949092126     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000442     Document Type: Article

References (37)

1. Wong CM and Ng IO: Molecular pathogenesis of hepatocellular carcinoma. Liver Int 28: 160-174, 2008.
2. Befeler AS and Di Bisceglie AM: Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122: 1609-1619, 2002.
3. Llovet JM, Bruix J and Gores GJ: Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 31: 1019-1021, 2000.
4. Satoh S, Daigo Y, Furukawa Y, et al: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24: 245-250, 2000.
5. De La Coste A, Romagnolo B, Billuart P, et al: Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851, 1998.
6. Pang A, Ng IO, Fan ST and Kwong YL: Clinicopathologic significance of genetic alterations in hepatocellular carcinoma. Cancer Genet Cytogenet 146: 8-15, 2003.
7. Zimmer DB, Cornwall EH, Landar A and Song W: The S100 protein family: history, function, and expression. Brain Res Bull 37: 417-429, 1995.
8. Schafer BW and Heizmann CW: The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 21: 134-140, 1996.
9. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-668, 2001.
10. Heizmann CW, Fritz G and Schafer BW: S100 proteins: structure, functions and pathology. Front Biosci 7: d1356-d1368, 2002.
11. Emoto Y, Kobayashi R, Akatsuka H and Hidaka H: Purification and characterization of a new member of the S-100 protein family from human placenta. Biochem Biophys Res Commun 182: 1246-1253, 1992.
12. 2+ binding properties. Eur J Biochem 207: 541-547, 1992.
13. Gribenko A, Lopez MM, Richardson JM, 3rd and Makhatadze GI: Cloning, overexpression, purification, and spectroscopic characterization of human S100P. Protein Sci 7: 211-215, 1998.
14. Arumugam T, Simeone DM, Van Golen K and Logsdon CD: S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 11: 5356-5364, 2005.
15. Gibadulinova A, Barathova M, Kopacek J, et al: Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells. Oncol Rep 14: 575-582, 2005.
16. Schor AP, Carvalho FM, Kemp C, Silva ID and Russo J: S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep 15: 3-6, 2006.
17. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, et al: Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54: 374-384, 2005.
18. Guerreiro Da Silva ID, Hu YF, Russo IH, et al: S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol 16: 231-240, 2000.
19. Logsdon CD, Simeone DM, Binkley C, et al: Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 63: 2649-2657, 2003.
20. Averboukh L, Liang P, Kantoff PW and Pardee AB: Regulation of S100P expression by androgen. Prostate 29: 350-355, 1996.
21. Diederichs S, Bulk E, Steffen B, et al: S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 64: 5564-5569, 2004.
22. Sato N, Fukushima N, Matsubayashi H and Goggins M: Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23: 1531-1538, 2004.
23. Hammacher A, Thompson EW and Williams ED: Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer. Int J Biochem Cell Biol 37: 442-450, 2005.
24. Shyu RY, Huang SL and Jiang SY: Retinoic acid increases expression of the calcium-binding protein S100P in human gastric cancer cells. J Biomed Sci 10: 313-319, 2003.
25. Bertram J, Palfner K, Hiddemann W and Kneba M: Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression. Anticancer Drugs 9: 311-317, 1998.
26. Beer DG, Kardia SL, Huang CC, et al: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824, 2002.
27. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704, 1993.
28. Grana X and Reddy EP: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219, 1995.
29. Soto Martinez JL, Cabrera Morales CM, Serrano Ortega S and Lopez-Nevot MA: Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15. Clin Transl Oncol 7: 156-164, 2005.
30. Higgins JP, Kaygusuz G, Wang L, et al: Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 31: 673-680, 2007.
31. Hwang MN, Ha TH, Park J, et al: Increased SOCS6 stability with PMA requires its N-terminal region and the Erk pathway via Pkcdelta activation. Biochem Biophys Res Commun 354: 184-189, 2007.
32. Chao A, Wang TH, Lee YS, et al: Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 119: 91-98, 2006.
33. Kita H, Hikichi Y, Hikami K, et al: Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J Gastroenterol 41: 1053-1063, 2006.
34. Nam SW, Park JY, Ramasamy A, et al: Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 42: 809-818, 2005.
35. Arumugam T, Simeone DM, Schmidt AM and Logsdon CD: S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE). J Biol Chem 279: 5059-5065, 2004.
36. Wang G, Platt-Higgins A, Carroll J, et al: Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients. Cancer Res 66: 1199-1207, 2006.
37. Beissel B, Silva ID, Pesquero JB, Russo J, Schor N and Bellini MH: S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct. Oncol Rep 17: 611-615, 2007.